A vaccine-derived polio case not too long ago confirmed in Gaza has led to a two-round vaccination marketing campaign focusing on 640,000 children set to start this weekend within the war-torn area.
Israel and Hamas have agreed to a phased, restricted 3-day pause in combating to facilitate the vaccinations, starting September 1.
Based on this week’s report from the International Polio Eradication Initiative (GPEI), one circulating vaccine-derived poliovirus sort 2 (cVDPV2) case was recognized earlier this month in Gaza, the primary case in 25 years.
Six cVDPV2-positive environmental samples have been reported in Gaza this yr.
In the present day, World Well being Group (WHO) Director-Normal Tedros NAME stated on X, “We welcome the dedication to humanitarian pauses in particular areas, and suspension of evacuation orders for the implementation of the marketing campaign. However the one lasting drugs is peace. The one approach to totally defend all the youngsters of Gaza is a ceasefire.”
We welcome the dedication to humanitarian pauses in particular areas, and suspension of evacuation orders for the implementation of the marketing campaign.
1.2 million vaccine doses prepared in Gaza
Tedros stated right this moment throughout WHO’s weekly briefing that greater than 1.2 million doses of vaccine have been delivered to Gaza, and a pair of,180 healthcare staff and neighborhood outreach staff have been skilled in vaccination methods. Tedros stated the purpose is 90% vaccination protection throughout every spherical of the marketing campaign
In different polio information, the GPEI famous extra wild poliovirus sort 1 (WPV1) circumstances in each Afghanistan and Pakistan.
In Afghanistan, 4 WPV1 circumstances had been reported in Kandahar, elevating this yr’s whole to 17 circumstances. In Pakistan, two WPV1 circumstances had been reported in Balochistan and Sindh, with 16 circumstances reported up to now this yr.
Chad, Nigeria, the Democratic Republic of the Congo, and South Sudan additionally recorded circumstances, all cVDPV2.
